ZA927837B - Monoclonal antibodiesto hepatitis C virus - Google Patents

Monoclonal antibodiesto hepatitis C virus

Info

Publication number
ZA927837B
ZA927837B ZA927837A ZA927837A ZA927837B ZA 927837 B ZA927837 B ZA 927837B ZA 927837 A ZA927837 A ZA 927837A ZA 927837 A ZA927837 A ZA 927837A ZA 927837 B ZA927837 B ZA 927837B
Authority
ZA
South Africa
Prior art keywords
hepatitis
virus
monoclonal
antibodiesto
cell line
Prior art date
Application number
ZA927837A
Other languages
English (en)
Inventor
Winand Johannes Antoniu Habets
Miriam Francisca Hen Klein-Rot
Theodorus Adrianus Oosterlaken
Sing Hiem Yap
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of ZA927837B publication Critical patent/ZA927837B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA927837A 1991-10-15 1992-10-12 Monoclonal antibodiesto hepatitis C virus ZA927837B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91202659 1991-10-15

Publications (1)

Publication Number Publication Date
ZA927837B true ZA927837B (en) 1994-03-11

Family

ID=8207945

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA927837A ZA927837B (en) 1991-10-15 1992-10-12 Monoclonal antibodiesto hepatitis C virus

Country Status (11)

Country Link
US (1) US5595868A (fi)
EP (1) EP0537856B1 (fi)
JP (1) JP3335387B2 (fi)
KR (1) KR100238559B1 (fi)
AT (1) ATE162553T1 (fi)
AU (1) AU670541B2 (fi)
CA (1) CA2080548C (fi)
DE (1) DE69224134T2 (fi)
ES (1) ES2114547T3 (fi)
FI (1) FI105275B (fi)
ZA (1) ZA927837B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2049679C (en) * 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens
US5753430A (en) * 1990-11-07 1998-05-19 Abbott Laboratories Monoclonal antibodies to hepatitis C virus and method for using same
EP0556320B1 (en) * 1990-11-07 1999-03-24 Abbott Laboratories Monoclonal antibodies to hepatitis c virus and method for using the same
JP3217600B2 (ja) * 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
CN1044384C (zh) * 1994-08-25 1999-07-28 中国药品生物制品检定所 抗丙型肝炎病毒抗原单克隆抗体细胞株建立及其单克隆抗体
US5849800A (en) * 1997-03-28 1998-12-15 The Penn State Research Foundation Use of amantadine for treatment of Hepatitis C
CA2316130A1 (en) * 1999-08-19 2001-02-19 Masanori Fukui Method for detection or determination of hcv core antigens and reagent for detection or determination for use therein
US7022323B2 (en) * 2001-06-26 2006-04-04 Progenics Pharmaceuticals, Inc. Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
US20030232745A1 (en) * 2001-06-26 2003-12-18 Olson William C. Uses of DC-sign and DC-Signr for inhibiting hepatitis C virus infection
US7049060B2 (en) * 2001-11-05 2006-05-23 Ortho-Clinical Diagnostics, Inc. HCV anti-core monoclonal antibodies
US7858752B2 (en) * 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
ES2456961T3 (es) 2007-02-21 2014-04-24 University Of Massachusetts Anticuerpos humanos contra el virus de la hepatitis C (VHC), usos de los mismos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1049686C (zh) * 1987-11-18 2000-02-23 希龙股份有限公司 非ａ和非ｂ肝炎病毒的诊断及疫苗
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide
KR0185373B1 (ko) * 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
EP0445801A3 (en) * 1990-03-08 1992-07-01 Kuraray Co., Ltd. Peptide and its use
JPH0436185A (ja) * 1990-03-28 1992-02-06 Kyowa Hakko Kogyo Co Ltd 融合抗原ポリペプチド
ZA912040B (en) * 1990-03-30 1991-12-24 Akzo Nv Peptides immunochemically reactive with antibodies directed against hepatitis non-a,non-b virus

Also Published As

Publication number Publication date
KR100238559B1 (ko) 2000-01-15
JP3335387B2 (ja) 2002-10-15
CA2080548C (en) 2003-07-01
CA2080548A1 (en) 1993-04-16
KR930008155A (ko) 1993-05-21
DE69224134D1 (de) 1998-02-26
AU2707992A (en) 1993-04-22
AU670541B2 (en) 1996-07-25
EP0537856B1 (en) 1998-01-21
FI105275B (fi) 2000-07-14
ATE162553T1 (de) 1998-02-15
ES2114547T3 (es) 1998-06-01
FI924641A (fi) 1993-04-16
FI924641A0 (fi) 1992-10-14
JPH05260960A (ja) 1993-10-12
EP0537856A1 (en) 1993-04-21
US5595868A (en) 1997-01-21
DE69224134T2 (de) 1998-07-02

Similar Documents

Publication Publication Date Title
ES2106195T3 (es) Anticuerpo igg aglicosilado anti cd3.
DK187889D0 (da) Dna-forbindelser og klonende vektorer, der koder for det monoklonale antistof ks1/4, samt chimere antistoffer afledt af ks1/4 og rettet mod et humant adenocarcinoma-antigen
EP0636029A4 (en) AGAINST CARCINOMA-ASSOCIATED ANTIQUE ANTIBODIES.
DK0733069T3 (da) Oprensede Primat CTLA-8-antigener og beslægtede reagenser
EP0134552A3 (en) Monoclonal antibody with a high affinity for digoxin
ZA927837B (en) Monoclonal antibodiesto hepatitis C virus
DK0538754T3 (da) Anvendelse af antistofholdige præparater til immunundertrykkelse
JPS56158718A (en) Monoclonal antibody against hepatitis b virus
EP0676966A4 (en) Antibodies directed against binding associated epitopes.
DE3885355D1 (de) Monoklonale Antikörper.
ZA973664B (en) Hepatitis b monoclonal antibodies
GB8910263D0 (en) Monoclonal antibodies specific for an immunoglobulin isotype
EP0569537A4 (en) Monoclonal antibodies to putative hcv envelope region and methods for using same
DK0585570T3 (da) Granulocytbindende antistofkonstrukter, deres fremstilling og anvendelse
WO1994021812A3 (en) Hepatitis b escape mutant specific binding molecules
DE3785795D1 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
EP0599913A4 (en) MONOCLONAL ANTIBODIES MOUNTING ON THE SUCCESSIVE NS5 PROTEINS OF HEPATITIS C VIRUS, AND METHODS OF USE THEREOF.
EP0600000A4 (en) HEPATITIS C DETECTION TEST USING RECOMBINANT ANTIGENS OF THE NS5 REGION.
EP0580758A4 (en) RECOMBINANT ANTI-HIV ANTIBODIES.
DE69023717D1 (de) Monoklonaler Antikörper.
Blood Monoclonal Antibodies
ITMI910660A0 (it) Anticorpi monoclonali come antidoti
GB9722943D0 (en) Hepatitis B virus monoclonal antibodies
GB9722944D0 (en) Hepatitis B virus monoclonal antibodies
ZA937033B (en) Reshaped monoclonal antibodies against an immunoglobulin isotype.